BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2423735)

  • 21. Expression of a candidate ataxia-telangiectasia group D gene in cultured fibroblast cell lines and human tissues.
    Hosoi Y; Kapp LN
    Int J Radiat Biol; 1994 Dec; 66(6 Suppl):S71-6. PubMed ID: 7530755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction and repair of DNA damage in normal and ataxia-telangiectasia skin fibroblasts treated with neocarzinostatin.
    Shiloh Y; van der Schans GP; Lohman PH; Becker Y
    Carcinogenesis; 1983; 4(7):917-21. PubMed ID: 6223717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity.
    Duchaud E; Ridet A; Stoppa-Lyonnet D; Janin N; Moustacchi E; Rosselli F
    Cancer Res; 1996 Mar; 56(6):1400-4. PubMed ID: 8640831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cells (normal and ataxia telangiectasia) transfected with pR plasmid are hypersensitive to DNA strand-breaking agents.
    Antonelli A; Elli R; Marcucci L; Bosi R; Kobal D; Petrinelli P
    Mutat Res; 1991 Jul; 255(1):11-8. PubMed ID: 1712424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
    Mirzayans R; Smith BP; Paterson MC
    Cancer Res; 1989 Oct; 49(20):5523-9. PubMed ID: 2507129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.
    Glisson B; Gupta R; Smallwood-Kentro S; Ross W
    Cancer Res; 1986 Apr; 46(4 Pt 2):1934-8. PubMed ID: 3004711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An attempt to transfer radiation resistance to an ataxia-telangiectasia cell line.
    Green MH; Lowe JE; James MR; Arlett CF
    Kroc Found Ser; 1985; 19():173-9. PubMed ID: 2999342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal breakage correlates with delayed lethality in normal and ataxia telangiectasia cell lines treated with bleomycin.
    MacLeod RA; Buchheim T; Kaufmann M; Drexler HG
    Mutat Res; 1996 Nov; 372(1):33-42. PubMed ID: 9003529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1.
    Chen YQ; de Foresta F; Hertoghs J; Avalosse BL; Cornelis JJ; Rommelaere J
    Cancer Res; 1986 Jul; 46(7):3574-9. PubMed ID: 3011251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of DNA-damaging agents on isolated spleen cells and lung fibroblasts from the mouse mutant "wasted," a putative animal model for ataxia-telangiectasia.
    Inoue T; Aikawa K; Tezuka H; Kada T; Shultz LD
    Cancer Res; 1986 Aug; 46(8):3979-82. PubMed ID: 2425937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repair of potentially lethal and sublethal damage induced by neocarzinostatin in normal and ataxia-telangiectasia skin fibroblasts.
    Shiloh Y; Tabor E; Becker Y
    Biochem Biophys Res Commun; 1983 Jan; 110(2):483-90. PubMed ID: 6220700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of a permanent pSV ori--transformed ataxia-telangiectasia cell line.
    Murnane JP; Fuller LF; Painter RB
    Exp Cell Res; 1985 May; 158(1):119-26. PubMed ID: 2987007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced inhibition of replicon initiation and chain elongation by neocarzinostatin in skin fibroblasts from patients with ataxia telangiectasia.
    Shiloh Y; Becker Y
    Biochim Biophys Acta; 1982 Dec; 721(4):485-8. PubMed ID: 6218825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of fibroblasts derived from ataxia-telangiectasia patients to calicheamicin gamma 1I.
    Sullivan N; Lyne L
    Mutat Res; 1990 Nov; 245(3):171-5. PubMed ID: 1700294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-repair deficiencies do not affect intercalator-induced cytotoxicity or DNA scission in human cells.
    Zwelling LA; Mattern MR
    Mutat Res; 1982; 104(4-5):295-304. PubMed ID: 6896737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced sensitivity to camptothecin in ataxia-telangiectasia cells and its relationship with the expression of DNA topoisomerase I.
    Smith PJ; Makinson TA; Watson JV
    Int J Radiat Biol; 1989 Feb; 55(2):217-31. PubMed ID: 2563396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal processing of transfected plasmid DNA in cells from patients with ataxia telangiectasia.
    RĂ¼nger TM; Poot M; Kraemer KH
    Mutat Res; 1992 Nov; 293(1):47-54. PubMed ID: 1383810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased clastogenicity and decreased inhibition of DNA synthesis by neocarzinostatin and tallysomycin in ataxia telangiectasia lymphoid cells.
    Cohen MM; Simpson SJ
    Mutat Res; 1983 Apr; 112(2):119-28. PubMed ID: 6188042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action of etoposide (VP-16-123) on human cells: no evidence for topoisomerase II involvement in excision repair of u.v.-induced DNA damage, nor for mitochondrial hypersensitivity in ataxia telangiectasia.
    Downes CS; Mullinger AM; Johnson RT
    Carcinogenesis; 1987 Nov; 8(11):1613-8. PubMed ID: 2822276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of cultured cells from patients with ataxia-telangiectasia.
    Elmore E; Swift M
    J Cell Physiol; 1976 Nov; 89(3):429-31. PubMed ID: 977661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.